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Abstract The autosomal recessive spinocerebellar atax-
ias are an exciting field of study, with a growing number
of causal genes and an expanding phenotypic spectrum.
SYNE1 was originally discovered in 2007 as the causal
gene underlying autosomal recessive spinocerebellar
ataxia 1, a disease clinically thought to manifest with
mainly pure cerebellar ataxia. Since the original report
SYNE1 mutations have also been identified in families
with motor neuronopathy and arthrogryposis but few
families have been screened as the gene is very large at
146 exons in length. We screened 196 recessive
and sporadic ataxia patients for mutations in SYNE1 using
next generation sequencing in order to assess its fre-
quency and extend the clinicogenetic spectrum. We
identified four novel truncating mutations spread
throughout the SYNE1 gene from three families living in
London that originated from England, Turkey and Sri
Lanka. The phenotype was mainly pure cerebellar ataxia
in two families, cognitive decline was present in all three
families, axonal neuropathy in one family and marked
spasticity in the Turkish family, with a range of disease
severities. Searching for genotype–phenotype correlations
in the SYNE1 gene, defects located near the 30 prime end
of the gene are more frequently associated with motor
neuron or neuromuscular involvement so far. Our data
indicate SYNE1 mutations are not an uncommon cause of
recessive ataxia with or without additional clinical fea-
tures in patients from various ethnicities. The use of next
generation sequencing allows the rapid analysis of large
genes and will likely reveal more SYNE1 associated cases
and further expand genotype–phenotype correlations.
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Introduction
The recessive spinocerebellar ataxias (ARCAs or SCARs)
are a complex group of neurodegenerative conditions
with significant genetic and clinical heterogeneity [1].
They are usually characterized by early-onset ataxia with
a variable range of other neurological manifestations
such as pyramidal signs, endocrine manifestations, epi-
lepsy, cognitive deterioration and peripheral neuropathy
[2, 3]. To date, there are over 70 genes that can cause
recessive ataxia and this includes 21 SCAR genes [4]. In
2007, SYNE1 was identified as a cause of pure cerebellar
phenotypes. It was termed recessive ataxia of Beauce
(SCAR8 or ARCA1, MIM# 610743), since it was orig-
inally identified in a number of French-Canadian families
originating from the Beauce and Bas-St-Laurent regions
of Quebec [5].
Subsequent investigations have identified more than 11
biallelic truncating mutations and one homozygous
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missense mutation in individuals originating from
Canada, France, Brazil and Japan with pure cerebellar
ataxia [6–9]. More recently families from Japan and
Turkey with homozygous truncating SYNE1 mutations
have been associated with a motor neuron phenotype in
addition to cerebellar ataxia [7, 10]. Furthermore,
heterozygous missense mutations in SYNE1 have been
identified in dominant muscular dystrophy and two
unrelated probands with Emery-Dreifuss muscular dys-
trophy (MIM# 612998) where only the exons contribut-
ing to the muscle specific isoform of SYNE1 were
investigated [11, 12]. Besides, homozygous acceptor
splice site mutations two basepairs 5-prime to exon 137
were identified in a consanguineous Palestinian pedigree
with myogenic arthrogryposis [13]. In addition defects in
SYNE1 have been shown to be increased in exome
sequencing studies of mental retardation and autism [14,
15].
SYNE1 encodes the spectrin repeat-containing nuclear
envelope protein 1, a structural protein expressed in various
tissues and believed to link the nucleoskeleton to the inner
and outer nuclear membrane, to membranes of cell orga-
nelles, to the actin cytoskeleton, and to the sarcomere in
muscle [11, 16, 17]. Data from mice suggest a critical role
in neurogenesis and neuronal migration for SYNE1 as an
organiser of nucleokinesis in the interplay with other
complex proteins such as SYNE2, SUN1 and SUN2 [18].
However, its direct functional role in the human central
nervous system, and particularly in the cerebellum, remains
understudied.
In this study, we examined an ethnically diverse UK
cohort of autosomal recessive families and sporadic cere-
bellar ataxia patients through a combination of targeted
next generation sequencing and exome sequencing, iden-
tifying biallelic SYNE1 mutations in three families from




All patients were recruited through the Neurogenetics
service at the National Hospital for Neurology and
Neurosurgery, Queen Square, London and gave
informed consent. All patients had a diagnosis of pro-
gressive cerebellar ataxia with either known autosomal
recessive or presumed sporadic inheritance with early-
onset disease. In total 196 patients were screened for
SYNE1 mutations through either exome sequencing (110
patients) or targeted next generation sequencing (86
patients).
Genetic analysis
DNA was extracted from peripheral leucocytes of all
patients in the diagnostic lab, using standard procedures.
Additional samples were taken from affected or unaffected
relatives to test for mutation segregation where appropriate
[19]. Exome sequencing libraries were prepared using
Illumina Nextera Rapid Capture Exome Kits following the
manufacturer’s recommendation. Libraries were indexed
and sequenced on an Illumina HiSeq2500 machine. A
custom sequencing panel was designed to amplify the
coding exons of SYNE1 using the Illumina Truseq Custom
Amplicon v1.5 Kits. Libraries were prepared in keeping
with the standard recommended protocol and then
sequenced on an Illumina MiSeq machine. Bioinformatic
analysis was the same for both exome sequencing and
targeted next generation sequencing: Reads were aligned to
the hg19 genome build using Novoalign with variant
calling performed using SAMtools and Genome Analysis
Toolkit Best Practices (GATK, Broad Institute). Variant
annotation was achieved with ANNOVAR and coverage
metrics were investigated using a modified in-house Bed-
tools coverageBed script. All SYNE1 annotations and
mutation locations given below are for the refseq
NM_033071 transcript (ENST00000423061).
The final list of called variants in SYNE1 was filtered
according to the following criteria:
(1) nonsynonymous variants present in a homozygous or
compound heterozygous state only, (2) Quality [30, (3)
depth[10 and (4) minor allele frequency in exome variant
server, ExAC and 1000 g\0.005.
Identified variants were confirmed using Sanger
sequencing (see Supplementary Table 1 for primers
employed) in affected cases and in parents or unaffected
siblings where available to confirm segregation or mutation
phase for compound heterozygous mutations.
Results
Family I—Patient I:1 and I:4 are siblings from a non-
consanguineous English family. The two siblings were
noted to be poor at sports in school and had poor hand-
writing. There was, however, no concern about gait or
balance until much later in life. Patient I:1 sustained a
significant head injury at the age of 21 and was noted to
have slightly slurred speech after his accident which was
attributed at the time to multiple jaw fractures. There was
no perceptible change in gait or coordination until the age
of 40 when he noticed difficulty rising from a chair and
sustained several falls when walking. He is currently
65 years of age and now has significant gait ataxia and
dysarthria. His 49-year-old sister (I:4) did not notice any
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deterioration in her gait until age 32 after she also was
involved in a road traffic accident. She has noticed a slowly
progressive deterioration in her gait and speech since this
time. Examination of both siblings was very similar with
both exhibiting clinical signs of cerebellar ataxia with
broken ocular pursuit, cerebellar dysarthria and limb and
gait ataxia. Reflexes were normal and there was no clinical
and electrophysiologic evidence of neuropathy. Investiga-
tions showed both had cerebellar atrophy on MRI (see
Fig. 1b for patient I:4).
Cognitive profile of the proband I:4 was as follows:
WAIS-III showed verbal IQ of 70 and performance IQ of
67. Verbal subtest scores were impaired (Arithmetic, Digit
Span), borderline impaired (Similarities) and low average
(Vocabulary). Performance subtest scores were impaired
(Block Design) and borderline impaired (Picture Comple-
tion, Picture Arrangement). Thus, current performance on
the WAIS-III reflects cognitive under-functioning. Overall,
memory skills were satisfactory. Thus, performance on a
test of verbal recognition memory was good (Recognition
Memory Test for Words: 95th percentile). Performance on
a test of visual recall memory was good (AMIPB Figure,
immediate: 25–50th percentile, and delayed: 50–75th per-
centile), and performance on a verbal learning task was
satisfactory (AMIPB List Learning, A1–A5:
25–50th percentile, A6: 25th percentile). In contrast, per-
formance on a test of visual recognition memory was poor
(recognition memory test for faces: 10th percentile).
Nominal skills are adequate (graded naming test:
10–25th percentile), and arithmetic skills were impaired
(graded difficulty arithmetic test).
Visuospatial skills were weak (VOSP Position Dis-
crimination: \5 % cut-off), and her copy of a complex
figure was poor (AMIPB Figure). In contrast, visuoper-
ceptual skills were satisfactory (VOSP incomplete letters:
[5 % cut-off). There was evidence of mild executive
dysfunction. Thus, phonemic verbal fluency was a little
reduced (‘S’: 10), her performance on the Stroop task was
impaired (\2nd percentile) and on the Hayling Sentence
Completion Task her performance was poor. In contrast,
she was able to identify 6/6 categories on the Modified
Card Sorting Test, albeit with a little prompting. Speed of
information processing was within normal limits (oral
symbol digit modalities test). Performance was abnormal
on a test of sustained attention (TEA, Elevator Counting:
5/7) and in the borderline impaired range on a test of
selective attention (TEA, Elevator Counting with Distrac-
tion: 5–10th percentile).
In summary, the cognitive scores of the proband
I:4 reflect cognitive under-functioning. On focal cognitive
Fig. 1 Family tree (a), sagittal
T1-weighted MR imaging
(b) and sequencing
chromatograms of two novel
SYNE1 compound
heterozygous segregating
truncating mutations in family
I (c)
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tests, the main findings are weak arithmetic skills, poor
visuospatial skills, evidence of executive dysfunction and
reduced speed of information processing. Performance on
tests of memory and naming were satisfactory, and
visuoperceptual skills were intact.
In both affected siblings, two novel compound
heterozygous truncating mutations were identified in exon
18 (c.1849G[T:p.E617X) and exon 99 (c.18431G[A:
p.W6144X) of SYNE1. One of the two unaffected siblings
was available for testing and carried only the exon 98
mutation confirming the mutation phase to be trans (see
Fig. 1c).
Family II—Patient II:1 is one of 11 siblings from con-
sanguineous parents (1st cousins) of Turkish origin. She
was completely well until age 18 years when she devel-
oped progressive gait ataxia and dysarthria. At age 23 she
was still mobilising without aid but had a high frequency of
falls and required adaptations to her home to ensure safety.
The patient is now 34 years old. She has 4 affected siblings
who all developed symptoms with onset in their late teens
and were reported to be very similar to the index case
although unfortunately neither clinical notes, nor DNA
were available as none of the other family members are
resident in the UK and contact has been interrupted.
Clinical examination of the index patient showed cognitive
difficulties at the bedside but she was not formally asses-
sed. There was broken pursuit eye movements, mild to
moderate finger nose ataxia and marked gait ataxia.
Reflexes were brisk in the lower limbs with sustained
clonus at both ankles and extensor plantar reflexes.
Brain MRI of the index case showed marked cerebellar
atrophy. Nerve conduction studies showed no evidence of
peripheral neuropathy. A novel homozygous variant in
exon 108 of SYNE1 (c.19897C[T p.Q6633X) was identi-
fied in the proband (see Fig. 2a, left panel). DNA for the
parents and siblings was not available.
Family III—The proband (III:1) is a 38-year-old Sri
Lankan man who originally developed gait and balance
problems at 22 years. He is the second of five siblings that
are all well and without neurological problems. The
patient’s parents were not known to be related. He was fit
and active in sports as a child and has despite the obvious
gait difficulties remained independent without usage of
walking aids till present. Clinical examination showed
hypermetric saccades, limb ataxia and extensor plantar
reflexes although reflexes were reduced. MRI brain is
shown above with cerebellar atrophy (Fig. 2b) and nerve
conduction studies showed an axonal neuropathy, other
screening blood tests were normal. The examination of this
patient is shown on the attached video (see Supplementary
Video 1).
Cognitive profile in the proband was as follows: WAIS-
III showed a verbal IQ of 76 and performance IQ of 78.
Verbal subtest scores were average (Arithmetic) low
Fig. 2 Chromatograms of two
novel mutations identified in
patient II:1 (left) and III:1
(right) (a) and sagittal T1-
weighted MR imaging of an
unaffected control proband, and
patient III:1 at age 32 (b)
1506 J Neurol (2016) 263:1503–1510
123
average (Digit Span), and borderline impaired (Similarities
and impaired Vocabulary). Performance subtest scores
were low average (Block Design, Picture Arrangement)
and borderline impaired (Picture Completion). Perfor-
mance was normal on a test of verbal memory (short
Recognition Memory Test for Words: 75th percentile). In
contrast, his scores were poor on two tests of visual
memory (Recognition Memory Test for Faces:
\10th percentile; AMIPB Figure Recall\5th percentile).
Naming skills were satisfactory when considering language
and cultural factors. He was able to name 16/30 items on
the Oldfield Naming Test. Performance was normal on
tests of visual perception and visual spatial functioning
(Incomplete Letters:[5 % cut-off, Position Discrimination:
[5 % cut-off). Performance was satisfactory on a test of
Arithmetic (Graded Difficulty Arithmetic Test:
10–25th percentile). Performance on the simple Stroop test
was satisfactory and he passed the Weigl Sorting test.
Processing speed is reduced (Symbol Digit Modalities Test
\5th percentile). His performance was poor on a test of
selective attention (Elevator Counting with Distraction).
In summary, the cognitive scores were mildly impaired
on both the verbal and performance scales of the WAIS-III.
On a series of focal cognitive tests he presented with a poor
performance on some tests of visual memory. In addition,
processing speed was reduced and performance was poor
on a test of selective attention.
A novel, truncating homozygous variant in SYNE1, exon
77 c.13429C[T:p.Q4477X was identified (See Fig. 2a,
right panel).
Discussion
To date, homozygous loss-of-function mutations in SYNE1
have been reported in French-Canadian, French, Japanese,
Turkish and Brazilian individuals [6, 7, 10]. With the first
British and Sri Lankan cases detected in this study, we
further extend the ethnic diversity underlying SYNE1
associated cerebellar ataxia. A summary of pheno- and
genotype of these and all other recently reported SYNE1
mutations can be seen in Table 1.
All novel cases reported in our study are associated with
truncating mutations likely to result in production of a
truncated protein and hence a complete loss or severe
reduction of protein function. Clinically, there was a range
in the disease age at onset and a possible negative corre-
lation between the position of the stop codon in the reading
frame and the severity or age at onset in our cases: e.g., our
Turkish case has the most 3-prime mutation of all four;
however, this patient presented with the earliest age at
onset (18 years) and additional pyramidal manifestations
absent in the other 3 cases. Additionally, looking at cases
I:1 and I:4 from our series, phenotypic heterogeneity can
Table 1 Reported SYNE1 mutations after the initial discovery in 2007
Family Case ID Ethnicity AAO
(years)
Mutation Clinical features References
1 I:1 White British 21 p.E617X ? p.W6144X Pure ataxia NHNN-cohort
2 I:4 White British 32 p.E617X ? p.W6144X Pure ataxia NHNN-cohort
3 II:1 Turkish 18 hom p.Q6633X Ataxia ? pyramidal tract signs NHNN-cohort
4 III:1 Sri Lankan 22 hom p.Q4477X Pure ataxia NHNN-cohort
5 II:10 French-Canadian 30 p.R125X ? p.W6620X Pure ataxia [6]
6 III:1 French-Canadian 14 p.R2906X ? p.R7084X Pure ataxia [6]
7 Case A Brazilian na hom p.Q1300X Ataxia—no further details [6]
8 Case B French na hom c.10753-10757delCCAAG/
predicted p.R3432Vfs*4
Ataxia—no further details [6]
9 Patient 1 Japanese 6 hom p.R7486fs7488X (?hom
p.G185R)
Ataxia; pyramidal signs, motor
neuron disease
[7]
10 Patient 2 Japanese 36 hom p.R3597X Pure ataxia [7]
11 Patient 3 Japanese 27 hom p.Y4534fs4539X Pure ataxia [7]
12 SYNE1 Turkish 20 hom p.Q7644X (=p.Q7573X for
ENST00000423061)
Ataxia; pyramidal tract signs,
motor neuron disease
[10]
13 SYNE2 Turkish 24 hom p.R7842X (=p.Q7771X for
ENST00000423061)
Ataxia; pyramidal tract signs,
motor neuron disease
[10]
Demographic, genetic and clinical summary of SYNE1 mutations reported after the initial discovery paper in 2007
Transcript ENST00000423061/RefSeq protein NP_149062 is used for reference, unless otherwise stated in the table
AAO age at onset, hom homozygous, na not available
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be observed within families. Even though based on very
low numbers of patients, these observations are mirrored
via the other recent reports in the literature (see Table 1;
Fig. 3) with SYNE1 associated cerebellar ataxia being rel-
atively mild and slowly progressive. Our affected cases
from families I and III are fairly typical of previously
reported cases, although the family from Sri Lanka had an
axonal neuropathy. Cognitive decline was evident in all
three families, which has been reported in the past in an
extensive report on patients from Quebec [20].
The proband from family II, however, exhibited marked
lower limb pyramidal signs with hyperreflexia and ankle
clonus. Of note, there were no variants in any other ataxia
or hereditary spastic paraparesis genes identified in the
exome sequence data of this individual. Recently, two
other Turkish families have been described with affected
members manifesting a spastic ataxia and motor neuron
phenotype associated with two novel homozygous SYNE1
nonsense mutations (R7842X and Q7644X) [10] (also see
Fig. 3 for all mutations associated with motor neuron dis-
ease as represented by yellow filled boxes).
Interestingly, all recent mutations presenting with sig-
nificant pyramidal signs were located towards the 30 prime
end of the gene and seemed to be homozygous mutations
and not compound heterozygous mutations. However, as
with the age at onset and disease severity, this observation
is interesting, but based on a very low number of cases.
Furthermore, one of the homozygous mutations reported in
the initial study in 2007 (p.Q7640X) is located far 30 prime
of the gene as well, but has been reported with pure
cerebellar ataxia as part of the initial cohort (see Fig. 3). It
is highly likely that further genetic, epigenetic and envi-
ronmental modifiers are contributing to the phenotypic
variability and it is recommended therefore that SYNE1
mutations be considered also in the aetiology of complex as
well as pure recessive ataxia. Further development and
establishment of next generation techniques in clinical
diagnostics will reduce costs and involved timespans till
diagnosis to enable SYNE1 associated cerebellar ataxia to
be more readily identified in the future. However, given the
significant size of this gene (146 coding exons, 27,436 base
pairs, 8749 amino acids), it is likely to inherently harbour a
great deal of genetic variation, and cautious interpretation
of identified variants will be needed to correctly infer true
pathogenic mutations as opposed to benign
polymorphisms.
Fig. 3 Locations of reported mutations associated with SYNE1 ataxic
phenotypes. Mutations in black are from the discovery study, blue
mutations are mutations reported since and red are the mutations
identified in our study. Yellow filled boxes mark mutations associated
with motor neuron phenotypes. Dotted lines connect the further
3-prime mutation with their partner mutation in compound heterozy-
gous cases. Cave: sizes of black bars do not proportionally represent
the sizes of the different 146 exons of SYNE1
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Conclusions
Here, we expand the ethnic and genetic diversity of SYNE1
associated cerebellar ataxia, an important gene to be
screened in recessive and sporadic cases. We demonstrate
four novel truncating mutations in SYNE1 in pedigrees
from British, Sri Lankan and Turkish origin. We observe a
range of inter-family severities, extra-cerebellar and cog-
nitive features and possible genotype–phenotype
correlations.
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